Skip to content

Physiologic Pacing Registry

Physiologic Pacing Registry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03719040
Enrollment
870
Registered
2018-10-25
Start date
2018-11-27
Completion date
2021-10-07
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bradycardia, Cardiomyopathies, Heart Block, Heart Failure, Sinus Node Dysfunction, Syncope, Ventricular Tachycardia

Brief summary

The Physiologic Pacing Registry is a prospective, observational, multi-center registry performed to gain a broader understanding of 1) physiologic pacing implant and follow-up workflows, including pacing and sensing measurements and 2) the clinical utility in creating a 3-dimensional electro-anatomical map of cardiac structures prior to physiologic pacing device implants based on the clinical site's routine care.

Detailed description

The Physiologic Pacing Registry will be conducted to gain a deeper understanding of physiologic pacing device implants and follow-up workflows, including device and programmer measurements to help inform Abbott's product and clinical data development efforts. Additionally, the registry will provide a broader understanding of the clinical utility in mapping physiologic pacing structures with the use of Abbott's EnSite Cardiac Mapping System with an electrophysiology catheter prior to device implants for those institutions where mapping is routine care prior to physiologic pacing device implant. The registry will include patients undergoing implantation of an Abbott pacemaker, defibrillator, or a cardiac resynchronization therapy (CRT) pacemaker (CRT-P) or CRT defibrillator (CRT-D) according to the clinical site's routine care. Only patients scheduled to receive an Abbott device may be enrolled to ensure proper device data collection for future software and other physiologic pacing product development. The decision to provide physiologic pacing therapy and selection of devices for implant are at the discretion of the implanting physician. Abbott will collect data on the use of all commercially available leads and associated implant tools based on the physician's discretion as part of routine clinical practice within the registry.

Interventions

DEVICEPhysiologic pacing device implant

An alternative and potentially more effective pacing strategy for patients with electrical conduction abnormalities is physiologic pacing. Physiologic pacing is achieved by delivering a pacing stimulus to a cardiac conduction structure, such as the bundle of His or left bundle branch (LBB) of the His-Purkinje system, with a permanent lead. Physiologic pacing activates the heart through the native His-Purkinje conduction system, thus offering the most physiologic pacing approach to correct electrical dyssynchrony. Physiologic pacing has emerged as a feasible and safe alternative to pacemaker therapy and CRT with clinical and electrophysiological advantages.

Sponsors

Abbott Medical Devices
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

1. Scheduled for implantation of an Abbott pacemaker, defibrillator, or CRT-P/D device with any commercially available pacing lead as part of a physiologic pacing procedure according to the clinical site's routine care. 2. At least 18 years of age. 3. Willing and able to comply with the prescribed follow-up tests and schedule of evaluations. 4. Provided written informed consent prior to any registry-related procedures.

Exclusion criteria

1. History of tricuspid valve repair or replacement. 2. Currently participating in another clinical study with an active treatment arm and belong to the active arm 3. Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the registry or to comply with follow-up requirements, or impact the scientific soundness of the registry results. 4. Chronic physiologic pacing lead implanted 5. Life expectancy of \< 6 months. 6. Known contraindication for physiologic pacing therapy/implant (i.e. ongoing infection, known occlusion of the subclavian vein, etc.).

Design outcomes

Primary

MeasureTime frameDescription
Physiologic Pacing Implant Success RateDuring procedure849 subjects underwent attempted implants of physiologic pacing leads. Implant success rate was based on investigator-reported outcome.
Pacing Capture Threshold for His Bundle Pacing6 MonthsThe pacing capture threshold was collected to characterize electrical performance in the Bundle of His area at 6 months. Pacing capture threshold is the minimum amount of voltage (V) needed to depolarize the myocardium or heart muscle with an electrical impulse from a pacemaker, ICD, or CRT.

Countries

Australia, Austria, Canada, Czechia, France, Germany, Hong Kong, India, Italy, Netherlands, Poland, Singapore, South Africa, Spain, Switzerland, United States

Participant flow

Recruitment details

A total of 870 subjects were enrolled in the registry

Participants by arm

ArmCount
Physiologic Pacing Registry
The registry is a single arm study
870
Total870

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up26
Overall StudyWithdrawal by Subject177

Baseline characteristics

CharacteristicPhysiologic Pacing Registry
Age, Continuous74.9 years
STANDARD_DEVIATION 10
Cardiomyopathy Type
Idiopathic
5 Participants
Cardiomyopathy Type
Ischemic
134 Participants
Cardiomyopathy Type
None
586 Participants
Cardiomyopathy Type
Non-ischemic
145 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
135 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
702 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
33 Participants
NYHA Class
Class I
98 Participants
NYHA Class
Class II
241 Participants
NYHA Class
Class III
137 Participants
NYHA Class
Class IV
9 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
32 Participants
Race (NIH/OMB)
Black or African American
31 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
17 Participants
Race (NIH/OMB)
White
789 Participants
Sex: Female, Male
Female
337 Participants
Sex: Female, Male
Male
533 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
23 / 870
other
Total, other adverse events
47 / 870
serious
Total, serious adverse events
95 / 870

Outcome results

Primary

Pacing Capture Threshold for His Bundle Pacing

The pacing capture threshold was collected to characterize electrical performance in the Bundle of His area at 6 months. Pacing capture threshold is the minimum amount of voltage (V) needed to depolarize the myocardium or heart muscle with an electrical impulse from a pacemaker, ICD, or CRT.

Time frame: 6 Months

Population: Subjects who did have a pacing lead implant successfully in bundle of His and complete the 6-month visit.

ArmMeasureValue (MEAN)Dispersion
Physiologic Pacing RegistryPacing Capture Threshold for His Bundle Pacing1.59 VoltsStandard Deviation 0.97
Primary

Physiologic Pacing Implant Success Rate

849 subjects underwent attempted implants of physiologic pacing leads. Implant success rate was based on investigator-reported outcome.

Time frame: During procedure

Population: The patient population for this analysis includes subjects underwent implantation of an Abbott pacemaker, defibrillator, or CRT-P/D with any market released pacing lead as part of a physiologic pacing procedure according to the clinical site's routine care.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Physiologic Pacing RegistryPhysiologic Pacing Implant Success Rate768 Participants
Post Hoc

Pacing Capture Threshold for Left Bundle Branch Area Pacing

The pacing capture threshold was collected to characterize electrical performance in the Left Bundle Branch area at 6 months. Pacing capture threshold is the minimum amount of voltage (V) needed to depolarize the myocardium or heart muscle with an electrical impulse from a pacemaker, ICD, or CRT.

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
Physiologic Pacing RegistryPacing Capture Threshold for Left Bundle Branch Area Pacing0.79 VoltsStandard Deviation 0.33

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026